Picture of TAUNS Laboratories logo

197A — TAUNS Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Table: Tauns Laboratories -2023/24 parent results

Aug 13 (Reuters)- 
          Tauns Laboratories, Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Jun 30, 2024    Jun 30, 2023   Jun 30, 2025     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             18.43           15.67          19.27                 
                 (+17.6 pct)     (-10.2 pct)    (+4.5 pct)               
  Operating          8.03            4.97           8.31                 
                 (+61.7 pct)     (-55.6 pct)    (+3.5 pct)               
  Recurring          7.84            4.95           8.32                 
                 (+58.3 pct)     (-55.8 pct)    (+6.1 pct)               
  Net                5.77            3.03           6.02                 
                 (+90.3 pct)     (-32.3 pct)    (+4.2 pct)               
  EPS             57.74 yen       30.35 yen      59.79 yen               
  EPS Diluted     53.99 yen                                              
  Ann Div         27.75 yen       9.00 yen       28.00 yen               
  -Q2 Div         6.00 yen        9.00 yen       6.00 yen                
  -Q4 Div         21.75 yen          NIL         22.00 yen               
  
  NOTE - Tauns Laboratories, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=197A.T

Recent news on TAUNS Laboratories

See all news